The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 18, 1982

Filed:

Mar. 03, 1980
Applicant:
Inventor:

William Rosenbrook, Jr, Libertyville, IL (US);

Assignee:

Abbott Laboratories, Chicago, IL (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07H / ;
U.S. Cl.
CPC ...
536 161 ; 424180 ;
Abstract

An improved process for producing 3-O-demethylfortimicins and other O-methyl-containing aminoglycoside antibiotics comprising the steps of reacting the fortimicin to be 3-O-demethylated with a borontrihalide and recovering the 3-O-demethylfortimicin from the reaction mixture. 3-O-Demethylfortimicin derivatives which can be prepared by this process include compounds represented by the formula: ##STR1## wherein: R.sub.1 and R.sub.2 are hydrogen or methyl with the limitation that one of either R.sub.1 or R.sub.2 must be hydrogen; R.sub.3 is hydrogen or methyl; R.sub.4 and R.sub.11 are the same or different members of the group consisting of hydrogen, acyl, aminoacyl, diaminoacyl, N-loweralkylaminoacyl, N,N-diloweralkylaminoacyl, hydroxy-substituted aminoacyl, loweralkyl, aminoloweralkyl, diaminoloweralkyl, hydroxyloweralkyl, N-loweralkylaminoloweralkyl, N,N-diloweralkylaminoloweralkyl, N-loweralkylaminohydroxyloweralkyl and N,N-diloweralkylaminohydroxyloweralkyl; R.sub.5 and R.sub.6 are hydrogen or amino with the limitation that one of either R.sub.5 and R.sub.6 must be hydrogen; R.sub.7 and R.sub.8 are selected from the group consisting of either hydrogen, hydroxy, amino and chloro with the limitation that one of either R.sub.7 or R.sub.8 must be hydrogen; R.sub.9 and R.sub.10 are hydrogen or hydroxy with the limitation that one of either R.sub.9 or R.sub.10 must be hydrogen; and the pharmaceutically acceptable salts thereof. Compounds other than those wherein R.sub.1 is hydrogen, R.sub.2 is methyl, R.sub.3 is hydrogen, R.sub.5 is amino, R.sub.8 is hydroxy and R.sub.10 is hydroxy when R.sub.4' -R.sub.5' is saturated, are novel and are useful as antibiotics, antibacterial agents, and as intermediates for producing other useful fortimicin derivatives.


Find Patent Forward Citations

Loading…